It was discovered that the levels of two of the four ribosomal fusion proteins encoded by human ubiquitins, RPS27A and UBA52, were elevated in patients with Alzheimer's disease and COVID-19 with Alzheimer's disease, respectively [28, 58]. This evidence concerns the gene UBA52 and COVID-19.